Nino's News

Welcome to Nino’s News. Our guest blogger, Anthony “Nino” Sireci, M.D. is vice president, clinical biomarker and diagnostics development, Loxo Oncology at Lilly. Dr. Sireci is a board-certified Clinical Pathologist and a practicing molecular pathologist. Prior to joining Loxo, he was an Assistant Professor of Pathology and Cell Biology at Columbia University and a medical director in the Laboratory of Personalized Genomic Medicine at Columbia Medical Center.

lung cancer treatment research biomarker testing
The Role of Biomarker Testing in Early-Stage NSCLC: Why It’s Not Just for Advanced Disease

The Role of Biomarker Testing in Early-Stage NSCLC: Why It’s Not Just for Advanced Disease

Advances in biomarker science are reshaping how patients are diagnosed with and manage early-stage lung…
December 15, 2025
oncogene testing RET lung cancer
Looking Ahead: The Future of Diagnostic Testing for Patients

Looking Ahead: The Future of Diagnostic Testing for Patients

Over the last fifteen years, the introduction of precision medicine has generated renewed hope for…
January 7, 2024
biomarker testing RET cancer
Finding the Right Time to Ask About Biomarker Testing

Finding the Right Time to Ask About Biomarker Testing

Increasingly, cancer care is being approached with precision medicine methods that can offer personalized medical…
July 27, 2023
cancer medical care team
Understanding the Role of a Care Team in Treatment Planning

Understanding the Role of a Care Team in Treatment Planning

When someone is diagnosed with cancer, it is critical that they and their caregivers take…
April 18, 2023
lung cancer research
The Importance of Biomarker Testing When Facing RET-Altered Cancers

The Importance of Biomarker Testing When Facing RET-Altered Cancers

Over the last decade and a half, there has been a rapid expansion of precision…
September 12, 2022